- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01442116
Evaluation of Regional Myocardial Dynamics at Physical Stress in Essential Hypertension
September 28, 2011 updated by: Nagehan Kucukler, Mustafa Kemal University
The study hypothesis is stress-related regional tissue dynamics is related to left ventricular outflow tract blood flow.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Antioch, Turkey, 31100
- Mustafa Kemal University School of Medicine, Department of Cardiology
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Essential hypertension
Exclusion Criteria:
- History of Myocardial Infarction
- Diabetes Mellitus
- Renal Failure
- Orthopedic problems
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Hypertensives
|
safety and efficacy of stress echocardiography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
measurement of LVOT velocity before and after exercise by echocardiography
Time Frame: 1 day (before and after exercise stress)
|
1 day (before and after exercise stress)
|
measurement of TDI S wave before and after exercise by echocardiography
Time Frame: 1 day (before and after exercise)
|
1 day (before and after exercise)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
myocardial regional functions measured by tissue Doppler imagination
Time Frame: 1 day
|
1 day
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Fatih Yalcin, MD, Mustafa Kemal University: Turkey
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2009
Primary Completion (Actual)
December 1, 2009
Study Completion (Actual)
December 1, 2009
Study Registration Dates
First Submitted
September 15, 2011
First Submitted That Met QC Criteria
September 27, 2011
First Posted (Estimate)
September 28, 2011
Study Record Updates
Last Update Posted (Estimate)
September 29, 2011
Last Update Submitted That Met QC Criteria
September 28, 2011
Last Verified
September 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HT60
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
BayerCompletedPrimary HypertensionChina
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Addpharma Inc.Completed
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Cytos Biotechnology AGCompletedMild Essential Hypertension | Moderate Essential HypertensionSwitzerland
Clinical Trials on stress echocardiography
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Azienda Ospedaliera OO.RR. S. Giovanni di Dio e...RecruitingRight Ventricular DysfunctionItaly
-
University of Missouri-ColumbiaCompletedObesity | Metabolic Syndrome
-
Hospices Civils de LyonRecruitingHereditary Hemorrhagic Telangiectasia | Rendu Osler DiseaseFrance
-
Medical University of ViennaUnknown
-
Centre Hospitalier Universitaire de NiceCompletedPulmonary HypertensionFrance
-
Technical University of MunichLudwig-Maximilians - University of MunichEnrolling by invitationCardiovascular Diseases | Pediatric CancerGermany
-
China Medical University HospitalUnknownCardiovascular Diseases | STEMI | NSTEMITaiwan
-
Mayo ClinicCompletedMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States
-
Albert Einstein Healthcare NetworkLantheus Medical ImagingCompletedMitral Annulus CalcificationUnited States